Skip to main content
VCbacked
Log inGet Started

Paradox Immunotherapeutics

Toronto, Canada

Paradox Immunotherapeutics is a pharmaceutical company that develops treatments for patients suffering from rare amyloid diseases.

$10.0M raised
Feb 2025
Venture - Series Unknown
BiotechnologyLife SciencePharmaceutical

Top Investors

Creative Destruction Lab (CDL)SymBiosis

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Paradox Immunotherapeutics

How much funding has Paradox Immunotherapeutics raised?
Paradox Immunotherapeutics has raised $10.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2025.
Who are Paradox Immunotherapeutics's investors?
Paradox Immunotherapeutics's investors include Creative Destruction Lab (CDL), SymBiosis.
Where is Paradox Immunotherapeutics headquartered?
Paradox Immunotherapeutics is headquartered in Toronto, Canada.
What does Paradox Immunotherapeutics do?
Paradox Immunotherapeutics is a pharmaceutical company that develops treatments for patients suffering from rare amyloid diseases.
What stage is Paradox Immunotherapeutics at?
Paradox Immunotherapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Paradox Immunotherapeutics — Funding & Investors." VCBacked, February 25, 2025, https://www.vcbacked.co/company/paradox-immunotherapeutics. Accessed June 4, 2026.
APA
VCBacked. (2025). Paradox Immunotherapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/paradox-immunotherapeutics
Wikipedia (cite web)
{{cite web |title=Paradox Immunotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/paradox-immunotherapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong